Atlas Trials

Dedifferentiated Liposarcoma

20 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Dedifferentiated Liposarcoma

RecordFirmDate
Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (NCT04979442)Rain Oncology Inc2021-07-14
Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas (NCT04242238)Memorial Sloan Kettering Cancer Center2020-01-22
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors (NCT03604783)Sumitomo Pharma America, Inc.2018-12-26
Nivolumab With and Without Ipilimumab and Radiation Therapy in Treating Patients With Recurrent or Resectable Undifferentiated Pleomorphic Sarcoma or Dedifferentiated Liposarcoma Before Surgery (NCT03307616)M.D. Anderson Cancer Center2017-10-04
Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall (NCT03651375)Maria Sklodowska-Curie National Research Institute of Oncology2017-02-11
Study of Abemaciclib in Dedifferentiated Liposarcoma (NCT02846987)Memorial Sloan Kettering Cancer Center2016-07-01
Selinexor in Advanced Liposarcoma (NCT02606461)Karyopharm Therapeutics Inc2016-01-04
Ph II Cabazitaxel DD Liposarcoma (NCT01913652)European Organisation for Research and Treatment of Cancer - EORTC2014-10-01
Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma (NCT00969917)Infinity Pharmaceuticals, Inc.2010-01-01

Track Dedifferentiated Liposarcoma automatically

Every clearance here is in the API, with alerts when new ones post.